NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71093-141-05 | 71093-141 | HUMAN PRESCRIPTION DRUG | METHOCARBAMOL | METHOCARBAMOL | TABLET, FILM COATED | ORAL | 20170208 | N/A | ANDA | ANDA203550 | ACI Healthcare USA, Inc. | METHOCARBAMOL | 750 mg/1 | 500 TABLET, FILM COATED in 1 BOTTLE (71093-141-05) |
71093-141-04 | 71093-141 | HUMAN PRESCRIPTION DRUG | METHOCARBAMOL | METHOCARBAMOL | TABLET, FILM COATED | ORAL | 20170208 | N/A | ANDA | ANDA203550 | ACI Healthcare USA, Inc. | METHOCARBAMOL | 750 mg/1 | 100 TABLET, FILM COATED in 1 BOTTLE (71093-141-04) |
71093-140-05 | 71093-140 | HUMAN PRESCRIPTION DRUG | METHOCARBAMOL | METHOCARBAMOL | TABLET, FILM COATED | ORAL | 20170208 | N/A | ANDA | ANDA203550 | ACI Healthcare USA, Inc. | METHOCARBAMOL | 500 mg/1 | 500 TABLET, FILM COATED in 1 BOTTLE (71093-140-05) |
71093-140-04 | 71093-140 | HUMAN PRESCRIPTION DRUG | METHOCARBAMOL | METHOCARBAMOL | TABLET, FILM COATED | ORAL | 20170208 | N/A | ANDA | ANDA203550 | ACI Healthcare USA, Inc. | METHOCARBAMOL | 500 mg/1 | 100 TABLET, FILM COATED in 1 BOTTLE (71093-140-04) |